D-0295-2022 Class I Ongoing

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0295-2022 was initiated by Teligent Pharma, Inc. on Nov 30, 2021 and is designated Class I. Reason for recall: Superpotent Drug The recall status is ongoing. Affected quantity: 6,816 bottles.

Recall Details

Product Type
Drugs
Report Date
Jan 5, 2022
Initiation Date
Nov 30, 2021
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,816 bottles

Product Description

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

Reason for Recall

Superpotent Drug

Distribution Pattern

Distributed to a wholesaler in CO who further distributed Nationwide in the USA

Code Information

Lot #: 16345, Exp. Date 01/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0295-2022
openFDA file date
Oct 6, 2026
Loaded by RegDataLab
Oct 12, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it. FDA may have changed the recall since.